MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Archives & Legacy
*Organization & Developments: Geron (Archives 2018-2020)
Parents
Archives & Legacy
Organization & Developments: Geron
Children
2018: 3 Reasons Geron Corporation Stock Could Be a Big Winner
2018: BioSci Research On Geron (Part IV): What The Binary Catalysts Powering A Stellar Grower Revealed_seekingalpha.com
2018: Geron announces discontinuation of Imetelstat collaboration by Janssen; shares down 68% premarket - Geron Corporation (NASDAQ:GERN)
2018: Geron continues rally, up 15% - Geron Corporation (NASDAQ:GERN)
2018: Geron Corp.: It's Hard Enough To Get A Drug To Market Without The Questionable Bearish Arguments_seekingalpha.com
2018: Geron Corporation (Part I): Elucidating The Substantial Prospects Of Imetelstat_seekingalpha.com
2018: Geron Faces A Make-Or-Break Catalyst This Week - Geron Corporation (NASDAQ:GERN)
2018: Geron Reports Imetelstat Oral Presentation at European Hematology Association Congress_seekingalpha.com
2018: Geron to update investors tomorrow on imetelstat deal with Janssen; shares down 2% after hours_seekingalpha.com
2018: Geron: Imetelstat's History Of Deaths And Safety Issues - Geron Corporation (NASDAQ:GERN)
2018: Geron: Interesting Times_seekingalpha.com
2018: Geron: The Good, The Bad And The Ugly - Geron Corporation (NASDAQ:GERN)
2018: Geron: What To Expect From This Embattled Biotech?_seekingalpha.com
2018: Geron's Imetelstat Hits A Grand Slam, But The Rally Is Just Beginning_seekingalpha.com
2018: Glancy Prongay & Murray LLP Announces Investigation on Behalf of Geron Corporation Investors (GERN)
2018: Johnson & Johnson Might Seal The Deal With Geron This Year - Geron Corporation (NASDAQ:GERN)
2018: Little Geron May Soon Be Nipping At The Heels Of Celgene And Incyte - Geron Corporation (NASDAQ:GERN)
2018: Making The Bull Case For Geron: Understanding The Risk/Reward Of Telomerase Biology - Geron Corporation (NASDAQ:GERN)
2018: The Toxicity Of Geron's Imetelstat May Lead To Accelerated FDA Approval - Geron Corporation (NASDAQ:GERN)
2019: Geron (GERN) Investor Presentation - Slideshow_seekingalpha.com
2019: Geron +12.7% on fast-track designation - Geron Corporation (NASDAQ:GERN)
2019: Geron: A Different Company_seekingalpha.com
2019: Geron: A Very Long Wait For A Very Long Shot - Geron Corporation (NASDAQ:GERN)
2019: Geron: A Very Long Wait For A Very Long Shot_seekingalpha.com
2019: Geron: Hold Despite Slim Premium As Promising Trials Await Funding_seekingalpha.com
2019: Geron: On The Move Again_seekingalpha.com
2019: Geron: Science And Silence_seekingalpha.com
2020: Geron Announces 2019 Accomplishments and Key Development Priorities for 2020_www.schwab.wallst.com